Targeting oncogenic ROS1 fusion proteins with crizotinib has shown promising clinical outcomes in non-small cell lung cancer (NSCLC) patients, but emergence of resistance to therapy has been reported.

⚠️ The latest stable version is only compatible with Julia v1.8.5 and higher. Cthulhu can help you debug type inference issues by recursively showing the type-inferred code until you find the exact ...

oneAPI.jl provides support for working with the oneAPI unified programming model. The package is verified to work with the (currently) only implementation of this interface that is part of the Intel ...